Document Detail

The potential benefit of granulocyte transfusion therapy.
MedLine Citation:
PMID:  2620247     Owner:  NLM     Status:  MEDLINE    
The future of granulocyte transfusions depends in large part upon our ability to overcome technical problems, particularly related to dose. Certainly the attempts at technical improvements have made an impact on granulocyte availability and donor pools large enough to support twice daily transfusions should also improve the efficacy of a series of transfusions. The majority of bacterial infections in neutropenic patients do not necessitate granulocyte transfusions due to the rapid empiric use of modern broad-spectrum antibiotics. However, a proportion still do, and selection of appropriate candidates for granulocyte transfusions may improve the outcome. The use in fungal infections remains experimental, but as has been said by others in addition to myself, should be studied. Issues of histocompatibility remain complex. Patients rendered severely immunocompromised may have less of an alloimmunization response to transfusion products, but alloimmunization continues to be a complication of granulocyte transfusions. Patients undergoing bone marrow transplant have the advantage of access to an HLA-matched marrow and granulocyte donor. The techniques of granulocyte transfusion therapy must continue to be improved and utilized in part because our microbial foes continue to change and to resist our antibiotic improvements. As George Bernard Shaw said: "There is at bottom only one genuinely scientific treatment for all diseases and that is to stimulate the phagocytes. Drugs are a delusion".
J P Dutcher
Related Documents :
23530307 - The impact of diabetes on ethnic disparities seen in kidney transplantation.
20448487 - Quality improvement in transplant anesthesia: which way forward?
24447807 - Severe acute renal failure in patients treated with glucagon-like peptide-1 receptor ag...
23245807 - Blockade of the renin-angiotensin system and renal tissue oxygenation as measured with ...
23146457 - Initial immunosuppression with or without basiliximab: a comparative study.
17589197 - Effect of tenofovir on renal glomerular and tubular function.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Cancer investigation     Volume:  7     ISSN:  0735-7907     ISO Abbreviation:  Cancer Invest.     Publication Date:  1989  
Date Detail:
Created Date:  1990-03-20     Completed Date:  1990-03-20     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8307154     Medline TA:  Cancer Invest     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  457-62     Citation Subset:  IM    
Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, New York, New York.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bacterial Infections / prevention & control
Blood Transfusion*
Granulocytes / transplantation*
Infection / therapy*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
Mycoses / therapy
Neutropenia / complications

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  In vitro chemosensitivity of two Ewing's sarcoma cell lines: implication for autologous bone marrow ...
Next Document:  Post-natal pattern of cell proliferation in retinal pigment epithelium of mice studied with tritiate...